Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Brandt

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Rheumatology|August 16, 2021
Successful Evaluation of Spinal Mobility Measurements With the Epionics SPINE Device in Patients With Axial Spondyloarthritis Compared to ControlsDavid Kiefer, Xenofon Baraliakos, Daniela Adolf, et al.
The Journal of Rheumatology|October 15, 2025
Predicting treatment outcomes in patients with psoriatic arthritis or axial spondyloarthritis: An artificial intelligence-driven approachAsmir Vodenčarević, Jan Brandt-Jürgens, Sara Bär, et al.
The Open Rheumatology Journal|May 13, 2010
Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritisUlf Müller-Ladner, Karin Rockwitz, Jan Brandt-Jürgens, et al.
Rheumatology and Therapy|June 8, 2022
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with SecukinumabUta Kiltz, Petros P Sfikakis, Karl Gaffney, et al.
BMJ Open|February 14, 2026
Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)Klaus Krueger, Frank Behrens, Jan Brandt-Juergens, et al.
Arthritis Care & Research|July 25, 2023
Global Functioning in Axial Spondyloarthritis is Stronger Associated With Disease Activity and Function Than With Mobility and Radiographic DamageDavid Kiefer, Jürgen Braun, Uta Kiltz, et al.
The Journal of Rheumatology|April 15, 2023
Clinical Relevance of Axial Radiographic Damage in Axial Spondyloarthritis: Evaluation of Functional Consequences by an Objective Electronic DeviceDavid Kiefer, Jürgen Braun, Varvara Chatzistefanidi, et al.
RMD Open|December 19, 2023
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trialMichaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Arthritis Research & Therapy|May 19, 2005
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximabXenofon Baraliakos, Joachim Listing, Jan Brandt, et al.
The Journal of Rheumatology|February 15, 2007
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitisXenofon Baraliakos, Joachim Listing, Martin Rudwaleit, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|August 16, 2021
Successful Evaluation of Spinal Mobility Measurements With the Epionics SPINE Device in Patients With Axial Spondyloarthritis Compared to ControlsDavid Kiefer, Xenofon Baraliakos, Daniela Adolf, et al.
The Journal of Rheumatology|October 15, 2025
Predicting treatment outcomes in patients with psoriatic arthritis or axial spondyloarthritis: An artificial intelligence-driven approachAsmir Vodenčarević, Jan Brandt-Jürgens, Sara Bär, et al.
The Open Rheumatology Journal|May 13, 2010
Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritisUlf Müller-Ladner, Karin Rockwitz, Jan Brandt-Jürgens, et al.
Rheumatology and Therapy|June 8, 2022
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with SecukinumabUta Kiltz, Petros P Sfikakis, Karl Gaffney, et al.
BMJ Open|February 14, 2026
Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)Klaus Krueger, Frank Behrens, Jan Brandt-Juergens, et al.
Arthritis Care & Research|July 25, 2023
Global Functioning in Axial Spondyloarthritis is Stronger Associated With Disease Activity and Function Than With Mobility and Radiographic DamageDavid Kiefer, Jürgen Braun, Uta Kiltz, et al.
The Journal of Rheumatology|April 15, 2023
Clinical Relevance of Axial Radiographic Damage in Axial Spondyloarthritis: Evaluation of Functional Consequences by an Objective Electronic DeviceDavid Kiefer, Jürgen Braun, Varvara Chatzistefanidi, et al.
RMD Open|December 19, 2023
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trialMichaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Arthritis Research & Therapy|May 19, 2005
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximabXenofon Baraliakos, Joachim Listing, Jan Brandt, et al.
The Journal of Rheumatology|February 15, 2007
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitisXenofon Baraliakos, Joachim Listing, Martin Rudwaleit, et al.
Pageof 5